SDF-1 fused to a fractalkine stalk and a GPI anchor enables functional neovascularization

Stem Cells

Volumn 31, Issue 9, 2013, Pages 1795-1805

  Stachel, Georg ^a   Trenkwalder, Teresa ^a   Götz, Franziska ^a   El Aouni, Chiraz ^a   Muenchmeier, Niklas ^b   Pfosser, Achim ^a   Nussbaum, Claudia ^b   Sperandio, Markus ^b   Hatzopoulos, Antonis K ^c,d   Hinkel, Rabea ^a   Nelson, Peter J ^b   Kupatt, Christian ^a  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arteriogenesis; CXCR4; Homing; Progenitor cells

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HYBRID PROTEIN; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ARTICLE; CELL SURFACE; CONTROLLED STUDY; EMBRYO CELL; HINDLIMB; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MONONUCLEAR CELL; SHEAR STRESS; STEM CELL MOBILIZATION;

ARTERIOGENESIS; CXCR4; HOMING; PROGENITOR CELLS;

ANIMALS; CELL ADHESION; CHEMOKINE CX3CL1; CHEMOKINE CXCL12; ENDOCYTOSIS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; STEM CELLS;

EID: 84883353169     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1439     Document Type: Article

References (51)

1. Chavakis E, Koyanagi M, Dimmeler S,. Enhancing the outcome of cell therapy for cardiac repair: Progress from bench to bedside and back. Circulation 2010; 121: 325-335.
2. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-1201.
3. Quevedo HC, Hatzistergos KE, Oskouei BN, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci 2009; 106: 14022-14027.
4. Fadini GP, Losordo D, Dimmeler S,. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 2012; 110: 624-637.
5. Williams AR, Hare JM,. Mesenchymal stem cells. Circ Res 2011; 109: 923-940.
6. Wollert KC, Drexler H,. Cell therapy for the treatment of coronary heart disease: A critical appraisal. Nat Rev Cardiol 2010; 7: 204-215.
7. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
8. Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1{alpha}. J Clin Invest 2007; 117: 1249-1259.
9. Turgeon J, Dussault S, Haddad P, et al. Probucol and antioxidant vitamins rescue ischemia-induced neovascularization in mice exposed to cigarette smoke: Potential role of endothelial progenitor cells. Atherosclerosis 2010; 208: 342-349.
10. Heida NM, Müller JP, Cheng IF, et al. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J Am Coll Cardiol 2010; 55: 357-367.
11. Vajkoczy P, Blum S, Lamparter M, et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003; 197: 1755-1765.
12. Ryzhov S, Solenkova NV, Goldstein AE, et al. Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circ Res 2008; 102: 356-363.
13. Zemani F, Silvestre JS, Fauvel-Lafeve F, et al. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol 2008; 28: 644-650.
14. Haider HK, Jiang S, Idris NM, et al. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1{alpha}/CXCR4 signaling to promote myocardial repair. Circ Res 2008; 103: 1300-1308.
15. Pfosser A, El-Aouni C, Pfisterer I, et al. NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: Novel role for LL37. Stem Cells 2010; 28: 376-385.
16. Zernecke A, Schober A, Bot I, et al. SDF-1{alpha}/CXCR4 axis is instrumental in murine neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005; 96: 784-791.
17. Malik M, Chen YY, Kienzle MF, et al. Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1+alpha through Lyn kinase. J Immunol 2008; 181: 4632-4637.
18. Potente M, Gerhardt H, Carmeliet P,. Basic and therapeutic aspects of angiogenesis. Cell 2011; 146: 873-887.
19. Jain RK,. Molecular regulation of vessel maturation. Nat Med 2003; 9: 685-693.
20. Schierling W, Troidl K, Troidl C, et al. The role of angiogenic growth factors in arteriogenesis. J Vasc Res 2009; 46: 365-374.
21. Hershey JC, Baskin EP, Corcoran HA, et al. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits. Heart Vessels 2003; 18: 142-149.
22. Kupatt C, Hinkel R, Pfosser A, et al. Cotransfection of vascular endothelial growth factor-a and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion: Role of vessel maturation. J Am Coll Cardiol 2010; 56: 414-422.
23. Hatzopoulos AK, Folkman J, Vasile E, et al. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 1998; 125: 1457-1468.
24. Kupatt C, Horstkotte J, Vlastos GA, et al. Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J 2005; 19: 1576-1578.
25. Hinkel R, Trenkwalder T, Pfosser A, et al. Therapeutic neovascularization via Thymosin beta4 overexpression requires AKT activation and capillary sprouting in the calf muscles: Evidence for backward signaling. Cardiovasc Res 2010; 87: S59.
26. Massberg S, Konrad I, Schurzinger K, et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006; 203: 1221-1233.
27. Langer H, May AE, Daub K, et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006; 98: e2-10.
28. Notohamiprodjo M, Djafarzadeh R, Mojaat A, et al. Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation. Protein Eng Des Sel 2006; 19: 27-35.
29. Pfosser A, El-Aouni C, Pfisterer I, et al. NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: Novel role for LL37. Stem Cells 2010; 28: 376-385.
30. Lebherz C, von Degenfeld G, Karl A, et al. Therapeutic angiogenesis/arteriogenesis in the chronic ischemic rabbit hindlimb: Effect of venous basic fibroblast growth factor retroinfusion. Endothelium 2003; 10: 257-265.
31. Schulz C, Schafer A, Stolla M, et al. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: A critical role for P-selectin expressed on activated platelets. Circulation 2007; 116: 764-773.
32. Liehn EA, Tuchscheerer N, Kanzler I, et al. Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol 2011; 58: 2415-2423.
33. Segers VFM, Tokunou T, Higgins LJ, et al. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007; 116: 1683-1692.
34. Tsou CL, Haskell CA, Charo IF,. Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 2001; 276: 44622-44626.
35. Hundhausen C, Schulte A, Schulz B, et al. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol 2007; 178: 8064-8072.
36. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697-703.
37. Zaruba MM, Theiss HD, Vallaster M, et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009; 4: 313-323.
38. Levesque JP, Hendy J, Takamatsu Y, et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003; 111: 187-196.
39. Aiuti A, Webb IJ, Bleul C, et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997; 185: 111-120.
40. Hendrix CW, Collier AC, Lederman MM, et al. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr 2004; 37: 1253-1262.
41. Jujo K, Hamada H, Iwakura A, et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci 2010; 107: 11008-11013.
42. Abbott JD, Huang Y, Liu D, et al. Stromal cell-derived factor-1{alpha} plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004; 110: 3300-3305.
43. Roncalli J, Renault MA, Tongers J, et al. Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization. J Am Coll Cardiol 2011; 57: 2444-2452.
44. Ziegler M, Elvers M, Baumer Y, et al. The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice/clinical perspective. Circulation 2012; 125: 685-696.
45. Hiasa K, Ishibashi M, Ohtani K, et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: Next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004; 109: 2454-2461.
46. Tang YL, Zhu W, Cheng M, et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circulation Res 2009; 104: 1209-1216.
47. Landsman L, Bar-On L, Zernecke A, et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009; 113: 963-972.
48. Galkina E, Ley K,. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 2292-2301.
49. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403-409.
50. George J, Afek A, Abashidze A, et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2005; 25: 2636-2641.
51. Medof ME, Nagarajan S, Tykocinski ML,. Cell-surface engineering with GPI-anchored proteins. Faseb J 1996; 10: 574-586.